Hypertensive urgency is defined as severely elevated blood pressure (SBP >180 and/or DBP >110–120 mm Hg) without evidence of new or worsening target-organ damage. [1-2] The 2024 AHA Scientific Statement recommends moving away from the term "hypertensive urgency" in favor of "asymptomatic markedly elevated BP" to avoid emotive language that may encourage unnecessary aggressive treatment. [2] The critical clinical task is distinguishing this from hypertensive emergency, which requires IV therapy and ICU admission. [1][3]
The following figure from the 2017 ACC/AHA guidelines illustrates the decision algorithm for managing hypertensive crises:
1. History
- Medication adherence: Nonadherence to prescribed antihypertensives is the most common precipitating factor — more than half of patients presenting with SBP ≥180 have already been prescribed ≥2 agents [3]
- Duration and chronicity of hypertension; baseline BP readings if available
- Timing of onset: sudden vs. gradual; any identifiable trigger (pain, anxiety, urinary retention, dietary indiscretion)
- Substance use: cocaine, amphetamines, sympathomimetics, NSAIDs, oral contraceptives, decongestants, high-dose glucocorticoids [3][5]
- Dietary sodium intake and recent changes
- Symptoms to characterize: headache, dizziness, epistaxis, anxiety — these are common but do NOT indicate end-organ damage [3]
- Important negatives: chest pain, dyspnea, focal neurologic deficits, visual changes, altered mental status, back/flank pain
2. Alarm Features (Ruling Out Hypertensive Emergency)
The BARKH mnemonic (Brain, Arteries, Retina, Kidney, Heart) helps identify target-organ damage: [2]
- Brain: encephalopathy (confusion, seizures, cortical blindness), focal neurologic deficits (stroke), severe headache with altered sensorium
- Arteries: tearing chest/back pain (aortic dissection), pulse differential between extremities
- Retina: papilledema, flame hemorrhages, cotton-wool spots
- Kidney: oliguria, hematuria, acute rise in creatinine
- Heart: acute pulmonary edema (dyspnea, orthopnea, crackles), chest pain with ischemic features (ACS)
- Any of these findings reclassifies the patient as hypertensive emergency requiring IV therapy and ICU admission [1][3]
3. Medications
Medications that can elevate BP: [3][5]
- NSAIDs (ibuprofen, naproxen, COX-2 inhibitors)
- Sympathomimetics/decongestants (pseudoephedrine)
- Oral contraceptives/estrogen
- Glucocorticoids
- Stimulants (amphetamines, methylphenidate)
- Illicit drugs (cocaine, methamphetamine)
- MAOIs (tyramine interaction)
- Erythropoietin, calcineurin inhibitors, VEGF inhibitors
- Tricyclic antidepressants, clozapine
Acute oral treatment options (if symptoms present but no end-organ damage): [3]
Contraindicated/avoid
- Sublingual nifedipine: unpredictable, excessive BP reduction with risk of cardiovascular events [3]
- IV hydralazine for urgency: unpredictable response, 18% risk of >80 mmHg SBP drop [3][6]
- IV medications in general are discouraged for hypertensive urgency [1][3]
Key pearl: Rapid-acting antihypertensives (oral clonidine, IV hydralazine, IV labetalol) produce excessive SBP reduction (>80 mmHg) in ~18–20% of patients and MAP reduction >25% in 38–46%, exceeding cerebral autoregulatory limits. [6] Long-acting oral agents (e.g., lisinopril, extended-release nifedipine) carry significantly lower risk of overshoot. [6]
4. Diet
- Sodium: Dietary sodium indiscretion is a common precipitant of acute severe hypertension [3]
- Counsel on DASH diet principles and sodium restriction (<2,300 mg/day, ideally <1,500 mg/day)
- Adequate hydration — volume depletion can worsen BP lability
- Avoid licorice (mineralocorticoid effect), excessive caffeine, and tyramine-rich foods if on MAOIs
5. Review of Systems
- Neuro: headache, visual changes, confusion, focal weakness/numbness, seizures
- Cardiac: chest pain, dyspnea, orthopnea, PND, palpitations, leg edema
- Vascular: tearing chest/back pain, claudication
- Renal: decreased urine output, hematuria, foamy urine
- Endocrine: episodic headache/sweating/palpitations (pheochromocytoma triad), weight gain, fatigue
- Psych: anxiety, panic symptoms
- ENT: epistaxis (common but not an end-organ damage marker)
6. Collateral History and Family History
- Confirm medication list and adherence from pharmacy records, family, or caregivers
- Family history of hypertension, early-onset CVD, stroke, renal disease
- Family history of pheochromocytoma/paraganglioma syndromes (MEN2, VHL, NF1) [7]
- Social context: access to medications, insurance status, health literacy — uninsured/underinsured patients are overrepresented [3]
7. Risk Factors
- Age >60 years [3]
- Black race (higher prevalence and severity) [3]
- Medication nonadherence — the single strongest predictor [3]
- Uninsured/underinsured status, lower-income areas [3]
- Obesity, sedentary lifestyle, insulin resistance [1]
- High sodium intake, low potassium intake [1]
- Obstructive sleep apnea [7]
- CKD, diabetes mellitus
- Alcohol overuse [1]
- Illicit drug use (cocaine, amphetamines) [3]
8. Differential Diagnosis
Cannot-miss diagnoses (i.e., hypertensive emergency masquerading as urgency):
- Acute aortic dissection — tearing pain, pulse differential, widened mediastinum
- Acute stroke (ischemic or hemorrhagic) — focal deficits, altered consciousness
- Hypertensive encephalopathy — confusion, seizures, papilledema
- Acute coronary syndrome — chest pain, ECG changes, troponin elevation
- Acute pulmonary edema/HF — dyspnea, crackles, B-lines on POCUS
- Eclampsia/preeclampsia — in pregnant or postpartum patients
- Pheochromocytoma crisis — paroxysmal HTN with headache, sweating, palpitations [1-2]
Mimics of hypertensive urgency
- Pain-driven hypertension (treat the pain)
- Anxiety/panic attack
- Medication withdrawal (clonidine, beta-blockers)
- White-coat effect
- Bladder distension/urinary retention
- Acute kidney injury from other causes
9. Past Medical History
- Prior hypertension diagnosis, duration, and baseline BP
- Previous hypertensive crises or ED visits for elevated BP
- History of CVD (MI, stroke, HF, PAD)
- CKD, diabetes, dyslipidemia
- Prior evaluation for secondary hypertension
- Surgical history (prior renal artery intervention, adrenalectomy, cardiac surgery)
- Pregnancy history (preeclampsia)
10. Physical Exam
Vital signs: Repeat BP in both arms using proper technique (seated, rested 5 min, correct cuff size); check for orthostasis [2]
Focused exam
- Fundoscopy: papilledema, hemorrhages, exudates (if present → emergency) [2]
- Neuro: mental status, cranial nerves, motor/sensory, gait — any focal deficit → emergency
- Cardiac: S3/S4 gallop, murmurs, JVD
- Lungs: crackles (pulmonary edema)
- Vascular: bilateral arm BPs, femoral pulses (coarctation), carotid/abdominal bruits (renovascular disease)
- Abdomen: renal bruits, pulsatile mass
Expected findings in urgency: Elevated BP with otherwise normal exam. BP often decreases with 30 minutes of quiet rest — in one study, ~1/3 of patients fell below 180/110 before any medication. [3]
11. Lab Studies
Recommended baseline workup: [2]
- BMP (creatinine, BUN, electrolytes — assess for AKI, hypokalemia suggesting hyperaldosteronism)
- CBC (microangiopathic hemolytic anemia in malignant HTN)
- Urinalysis (proteinuria, hematuria, casts)
- Troponin if chest pain or dyspnea present
Expected in urgency: Normal or at-baseline labs. Any acute abnormality (rising creatinine, elevated troponin, schistocytes) reclassifies as emergency.
Monitoring: Recheck creatinine and electrolytes at follow-up visit
12. Imaging
- Chest X-ray: Assess for cardiomegaly, pulmonary edema, widened mediastinum [2]
- CT angiography: Only if aortic dissection suspected (tearing pain, pulse differential)
- CT head: Only if neurologic symptoms present
- Renal ultrasound/Doppler: Consider outpatient if secondary hypertension suspected (renal artery stenosis, CKD)
- Imaging is generally unnecessary in asymptomatic hypertensive urgency without alarm features
13. Special Tests
- Point-of-care ultrasound (POCUS): Cardiac (LV function, pericardial effusion), lung (B-lines for pulmonary edema), IVC (volume status) — rapid bedside assessment to rule out emergency
- Fundoscopic exam: Critical for identifying malignant hypertension (papilledema, flame hemorrhages)
- Urine drug screen: If sympathomimetic use suspected
- Outpatient secondary HTN workup (if indicated): aldosterone/renin ratio, plasma/urine metanephrines, TSH, renal artery duplex, sleep study [1][7]
14. ECG
- Indications: Obtain in all patients with markedly elevated BP presenting to the ED [2]
- Expected findings: May show LVH (chronic hypertension), which is not acute end-organ damage
- Concerning patterns: ST-segment changes (ischemia/infarction), new T-wave inversions, arrhythmias, strain pattern with acute symptoms
- Normal ECG supports the diagnosis of urgency over emergency
15. Assessment
Clinical summary: Hypertensive urgency is a common, low-acuity presentation that is 2–3× more common than hypertensive emergency. [3] It is not associated with adverse short-term outcomes and can be managed in the ambulatory setting. [3]
Severity stratification
- Asymptomatic with SBP >180 → quiet rest, reassess, reinstitute/intensify oral meds
- Symptomatic (headache, epistaxis, anxiety) without end-organ damage → oral antihypertensive, observe, discharge with follow-up
- Any evidence of end-organ damage → reclassify as emergency
Complications to consider: While short-term risk is low, episodes of severe hypertension carry long-term cardiovascular implications and signal the need for improved chronic BP management. [3]
16. Treatment Plan
Initial management
- Quiet rest for 30 minutes with repeat BP — resolves ~1/3 of cases [3]
- Address precipitants: pain, anxiety, urinary retention, medication nonadherence
- Reinstitute or intensify oral antihypertensive medications — this is the guideline-recommended approach [1][3]
If symptomatic (headache, epistaxis) without end-organ damage:
- Oral captopril 25–50 mg, or oral labetalol 200–400 mg, or oral clonidine 0.1–0.2 mg [3]
- May repeat every 30 minutes until symptoms improve
- Prefer long-acting agents (lisinopril, amlodipine, extended-release nifedipine) to minimize overshoot risk [6]
What NOT to do
- Do not give IV antihypertensives for urgency [1]
- Do not use sublingual nifedipine [3]
- Do not target normalization of BP acutely — goal is symptom improvement and gradual reduction over days to weeks [1]
- Observational data show that initiation of as-needed IV or oral antihypertensives in hospitalized patients with asymptomatic severe HTN is associated with increased risk of AKI, in-hospital mortality, and prolonged stay [1]
17. Disposition
Discharge criteria (most patients)
- No evidence of target-organ damage on history, exam, and basic workup
- Symptoms improved (if present)
- BP trending down or stable (does not need to be "normal" — discharge is reasonable once below ~160–180/100–110 mm Hg) [3]
- Oral antihypertensive regimen prescribed or adjusted
- Follow-up arranged within 1–7 days [3]
Admission criteria
- Any evidence of new/worsening target-organ damage (→ hypertensive emergency)
- Inability to exclude end-organ damage
- Persistent symptoms despite treatment
- Unreliable follow-up or medication access
Specialist consultation triggers
- Suspected secondary hypertension (young patient, resistant HTN, hypokalemia)
- Suspected pheochromocytoma or renovascular disease
- Refractory BP despite multi-drug regimen
18. Follow Up / Return Precautions
Follow-up timing: Within 1–7 days with PCP or hypertension specialist [3]
Return precautions — instruct patients to return immediately for:
- Severe headache with confusion or vision changes
- Chest pain or shortness of breath
- Weakness or numbness on one side of the body
- Difficulty speaking
- Severe back or abdominal pain
Patient counseling
- Emphasize medication adherence as the single most important intervention [3]
- Discuss sodium restriction, weight management, alcohol moderation
- Home BP monitoring with a validated device
- Expected recovery: BP should be gradually controlled over days to weeks, not hours
Long-term considerations: Patients without a clear precipitant or with treatment-resistant hypertension should be evaluated for secondary causes (primary aldosteronism, renovascular disease, pheochromocytoma, OSA). [1][7]
References
1. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. — Jones DW, Ferdinand KC, Taler SJ, et al. Journal of the American College of Cardiology. 2025.
2. The Management of Elevated Blood Pressure in the Acute Care Setting: A Scientific Statement From the American Heart Association. — Bress AP, Anderson TS, Flack JM, et al. Hypertension. 2024.
3. Acute Severe Hypertension. — Peixoto AJ. The New England Journal of Medicine. 2019.
4. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. — Whelton PK, Carey RM, Aronow WS, et al. Journal of the American College of Cardiology. 2018.
5. Arterial Hypertension. — Brouwers S, Sudano I, Kokubo Y, Sulaica EM. Lancet. 2021.
6. Acute Blood Pressure Reduction Exceeding Safety and Autoregulatory Limits Following Rapid-Acting Antihypertensives for Hypertensive Urgency. — Preston RA, Caizapanta EV, Afshartous D, et al. Journal of Hypertension. 2026.
7. Diagnosis and Management of Resistant Hypertension. — Azizi M, Vongpatanasin W, Fisher NDL, et al. The Journal of the American Medical Association. 2026.